The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Marketwire

ProMetic Announces Details of the Conference Call/Webcast for Its Second Quarter 2010 Financial Results

Thursday, August 05, 2010

ProMetic Announces Details of the Conference Call/Webcast for Its Second Quarter 2010 Financial Results17:00 EDT Thursday, August 05, 2010MONTREAL, QUEBEC--(Marketwire - August 5, 2010) - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") today announces that the Company will be holding a conference call / webcast on Wednesday, August 11, 2010, at 10:30 (EDT) further to the release of its Second Quarter 2010 financial results after the close of market on Tuesday, August 10, 2010. The numbers to access the conference call are (416) 800-1066 (international) and 1 (866) 212-9079 (North America toll free). A live audio webcast of the conference call will be available through ProMetic's website at audio replay of the call will be available for a period of seven days as of Wednesday, August 11, 2010, at 13:00 (EDT). The number to access the audio replay is 1 (800) 583-1035 using access code 8025830#. The replay of the web cast may be downloaded directly from ProMetic's web site.About ProMetic Life Sciences Inc.ProMetic Life Sciences Inc. ("ProMetic") ( is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand(TM) technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montreal (Canada), ProMetic has R&D facilities in the UK, the US and Canada, manufacturing facilities in the UK and business development activities in the US, Europe, Asia and in the Middle-East.FOR FURTHER INFORMATION PLEASE CONTACT: Company inquiries: ProMetic Life Sciences Inc. Pierre Laurin, President and CEO 514-341-2115 or ProMetic Life Sciences Inc. Anne Leduc Manager, Investor Relations & Communications 514-341-2115